Third Generation CAR T Cell Study Supports Use Of BioOra's Automated Manufacture For Phase 2 Trial

BioOra together with its founding partner, the Malaghan Institute of Medical Research, announced clinical results from the ENABLE phase 1 clinical trial at the 65th American Society of Hematology (ASH) Annual Meeting in San Diego.

Related Keywords

San Diego ,California ,United States ,New Zealand ,American ,Rob Weinkove ,Malaghan Institute Clinical ,American Society Of Hematology ,Malaghan Institute ,Malaghan Institute Of Medical Research ,Wellington Zhaotai Therapies Limited ,Third Generation ,Cell Study Supports Use Of Bioora ,Automated Manufacture For Phase ,Medical Research ,American Society ,Annual Meeting ,Clinical Director ,Principal Investigator ,Carl June ,Randi Grant ,Bio Ora ,Sci Tech ,Medical ,Ewsworthy ,Scoop ,